Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
about
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.Targeting human SET1/MLL family of proteins.Overexpression of IGFBP3 is associated with poor prognosis and tumor metastasis in nasopharyngeal carcinoma.Aberrant chromatin remodeling in gynecological cancer.Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
P2860
Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@ast
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@en
type
label
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@ast
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@en
prefLabel
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@ast
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@en
P2093
P2860
P1476
Integrated genomic analysis su ...... lial nasopharyngeal carcinoma.
@en
P2093
Andrew D Skol
Ezra E W Cohen
Kenan Onel
Lindsay V Rhodes
Mark M Sasaki
Rachelle Chambers
P2860
P304
P356
10.1158/1055-9965.EPI-15-0275
P577
2015-05-26T00:00:00Z